VHL loss could activate NF-κB pathways [107], thereby inducing gene expression of anti-apoptotic Bcl-xL and Bcl-2, and inhibiting tumor suppressor p53, highlighting the potential role in RCC development [108]. This evidence concerns the gene VHL and renal cell carcinoma.